Podcasts about Thomas Jefferson University

Continuing his exploration of once-weekly insulins, Neil Skolnik speaks with Aaron King, MD. Together, they cover the mechanisms, practical considerations, and the myriad benefits that this new therapy can have over daily basal insulin. This special episode is sponsored with support from Novo. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Aaron King, MD. Trained in the United States Navy in Family Medicine and certified by the American College of Diabetology, Dr. King practices outpatient diabetes management in San Antonio, Texas. Selected references: Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin. N Engl J Med 2023;389:297-308 Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy. N Engl J Med 2025;393:325-335

There is a fundamental link between diabetes and kidney care. But while there are many medications available to improve CKD outcomes in people with type 2 diabetes, the same options are not available for people with type 1. In this special episode, Dr. Neil Skolnik speaks with Janet McGill, MD, MA, FACE, FACP about the underdiscussed prevalence of CKD in type 1 and the importance of continued development in this area. This special episode is sponsored with support from Bayer. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Janet B. McGill, MD, MA, FACE, FACP, Professor of Medicine at the University of Washington's John T. Milliken Department of Medicine, Division of Endocrinology, Metabolism, and Lipid Research Selected References: Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026. The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1):S246–S260 Finerenone in Type 1 Diabetes and Chronic Kidney Disease. N Engl J Med 2026;394:947-957 Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 2020;383:2219-2229 Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 2020;383:1436-1446 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med 2024;391:109-121

About our Guests: Fran Balamuth, MD, PhD, MSCE, is division chief of Pediatric Emergency Medicine at the Children's Hospital of Philadelphia. Dr. Balamuth's research interests focus on pediatric sepsis recognition using epidemiologic and translational approaches, for which she has received NIH and foundation funding. She is the co-PI of the PROMPT BOLUS trial, a multinational pragmatic trial comparing saline vs balanced fluids in pediatric sepsis, which will be the largest acute care pediatric trial in history. In addition, she co-leads the CHOP Pediatric Sepsis Program, which supports and promotes local clinical, research, educational, and quality-improvement initiatives related to sepsis. She is an internationally recognized sepsis leader, and has been invited to serve on the national steering committee for the Improving Pediatric Sepsis Outcomes quality collaborative through the US Children's Hospital Association, and 2 international task forces focused on defining pediatric sepsis through the US Centers for Disease Control and Prevention and the Society of Critical Care Medicine.Scott L. Weiss, MD, MSCE, FCCM, is a Professor of Pediatrics & Pathology and Genomic Medicine at Thomas Jefferson University and division chief of Critical Care Medicine at Nemours Children's Hospital, Delaware. Previously, Dr. Weiss was on the faculty at the Children's Hospital of Philadelphia, where he earned recognition as an international expert in pediatric sepsis. Dr. Weiss' NIH-funded research focuses on epidemiology, fluid resuscitation, and mitochondrial dysfunction in pediatric sepsis. Dr. Weiss is an international expert in pediatric sepsis and served as the co-PI of the PRoMPT BOLUS trial.Nathan Kuppermann, MD, MPH, is Executive Vice President and Chief Academic Officer of Children's National Hospital and Director of the Children's National Research Institute. He also serves as chair of the Department of Pediatrics and associate dean of Pediatric Academic Affairs at the George Washington University School of Medicine and Health Sciences. He is an internationally recognized clinical trialist in pediatric trauma, pediatric DKA, and acute pediatric infections. As the original chair of the Pediatric Emergency Medicine Applied Research Network (PECARN); his research is focused on clinical trials and clinical prediction rules using large cohorts of acutely ill and injured children. Dr. Kuppermann served as the senior investigator of the PRoMPT BOLUS trial.Selected References:Weiss SL, Balamuth F, Long E, Thompson GC, Hayes KL, Katcoff H, Cook M, Tsemberis E, Hickey CP, Williams A, Williamson-Urquhart S, Borland ML, Dalziel SR, Gelbart B, Freedman SB, Babl FE, Huang J, Kuppermann N; Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PRoMPT BOLUS) Investigators of the PECARN, PERC, and PREDICT Networks. PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial. Trials. 2021 Nov 6;22(1):776. doi: 10.1186/s13063-021-05717-4. Erratum in: Trials. 2025 Oct 7;26(1):390. doi: 10.1186/s13063-025-09164-3. PMID: 34742327; PMCID: PMC8572061.Weiss SL, Balamuth F, Thurm CW, Downes KJ, Fitzgerald JC, Laskin BL. Major Adverse Kidney Events in Pediatric Sepsis. Clin J Am Soc Nephrol. 2019 May 7;14(5):664-672. doi: 10.2215/CJN.12201018. Epub 2019 Apr 18. PMID: 31000518; PMCID: PMC6500940.Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, Stollings JL, Kumar AB, Hughes CG, Hernandez A, Guillamondegui OD, May AK, Weavind L, Casey JD, Siew ED, Shaw AD, Bernard GR, Rice TW; SMART Investigators and the Pragmatic Critical Care Research Group. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med. 2018 Mar 1;378(9):829-839. doi: 10.1056/NEJMoa1711584. Epub 2018 Feb 27. PMID: 29485925; PMCID: PMC5846085.Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show.Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com.  You can also check out our website at http://www.pedscrit.com. Thank you for listening to this episode of PedsCrit!

Years ago, two friends in Philadelphia — both designers, both obsessed with jazz — kept noticing the same notation on the back of their favorite records: “recorded by Van Gelder in Hackensack.” So one Saturday they drove out to find it. They tracked down the address in a 1955 phone book, pulled up — and found a parking lot. No sign, no plaque, nothing to mark that Rudy Van Gelder had once turned his parents' living room into a recording studio there, capturing some of the most important American music of the century. This is a preview of a premium episode. To hear the whole thing, head over to our Substack:⁠https://designbetterpodcast.com/p/chris-entwisle-and-mark-havens⁠ That quiet drive home planted the seed for a twenty-year project. Mark Havens and Chris Entwisle are the authors of WAIL: The Visual Language of Prestige Records — the first real look at the design history of a label that, unlike Blue Note, never got its design mythology, despite cover art that's just as striking and durable. They tracked down original pressings, interviewed the designers before that history disappeared for good, and uncovered how a label run, in one historian's words, “like a mom and pop store” — no budget, no briefs, no marketing department — produced a visual identity coherent enough to still echo through design today. Buy the book What we love about this conversation is how much of it comes down to constraints driving creativity. Reid Miles couldn't afford imagery, so he made typography the art. Tom Hannon had no budget for stock photography, so he shot the musicians himself. Designers got an album title and nothing else — no brief, no comp, no client approval — and turned that absence of direction into creative freedom, because Bob Weinstock simply “viewed it all as art,” the music and the covers alike. This is a conversation about jazz, but it's also about what happens to creative work when nobody's watching too closely, and why limitations so often produce things that last. Bios Chris Entwisle is an artist and illustrator. For over thirty years, he has used his passion for both jazz and postwar graphic design in his illustration work. Entwisle has a BA in graphic design from Rutgers University. He and his wife live in the Philadelphia area. Mark Havens is an artist and educator with a dual background in graphic and industrial design. His work has been exhibited internationally and is held in both public and private collections. Out of Season, his first major monograph, was described by the New York Times as “a decade-long elegy.” Havens is a professor of industrial design at Thomas Jefferson University. *** Premium Episodes on Design Better This is a premium episode on Design Better. We release two premium episodes per month, along with two free episodes for everyone. New premium subscriber benefit: we've launched a private Slack workspace…join now to connect with designers, product leaders & creative practitioners in our community. And get a behind-the-scenes pass to every episode with The Roundup, where each week we bring you insights and actionable tactics from recent episodes. Premium subscribers get access to the documentary Design Disruptors and our growing library of books. You'll also get access to our monthly AMAs with former guests, ad-free episodes, discounts and early access to workshops, and our monthly newsletter The Brief that compiles salient insights, quotes, readings, and creative processes uncovered in the show. And subscribers at the annual level now get access to the Design Better Toolkit, which gets you major discounts and free access to tools and courses that will help you unlock new skills, make your workflow more efficient, and take your creativity further. Upgrade to paid Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to the latest episode (July 2026) of DOC Updates, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Updates: Aroda V, Buzzetti R, Dalskov S et al. "Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study." The Lancet Diabetes & Endocrinology, 2026; 0 doi: 10.1016/S2213-8587(26)00126-9 Bajaj H, Welch M, Shah P et al. "Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial." The Lancet, 2026; 407, 2402-2413 doi: 10.1016/S0140-6736(26)00967-0 Melville, N. "CGM Monitoring Benefits Extend to Non-Insulin-Using T2D." Medscape, June 07, 2026 Aronne, L.J., Horn, D.B., le Roux, C.W. et al. "Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial." Nat Med(2026) doi: 10.1038/s41591-026-04386-7 Salive ME, Tjaden AH, Ames JR, et al. "Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes." JAMA. Published online June 15, 2026. doi:10.1001/jama.2026.8492 Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health For information about the American Diabetes Association's scholarly journals, visit diabetesjournals.org. For more about this podcast, visit About Diabetes Core Update.

In this special edition of DOC Updates, Neil Skolnik speaks with Dr. Juan Frias, who catalogues the latest cardiometabolic medications, emphasizing the distinguishing characteristics of each. This special episode is sponsored with support from Lilly. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Juan Pablo Frias, MD, Medical Director and Principal Investigator, Los Angeles Institute for Metabolic Research, Adjunct Professor of Medicine at Charles Drew University of Medicine and Science

For millions of people living with diabetes, insulin isn't optional—it's essential. Yet too many individuals and families continue to face impossible choices because of its cost. In the latest episode of Diabetes Day by Day, hosts are joined by Lisa Murdock, chief advocacy officer at the American Diabetes Association® (ADA), to discuss why insulin affordability remains one of the most important issues affecting the diabetes community today, what the INSULIN Act of 2026 could mean for people living with diabetes and their families, and how you can help create change. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Lucia M. Novak, MSN, ANP-BC, BC-ADM, President and Founder of Diabesity LLC; Co-Executive Director, Diabetologist, and Obesity Management Specialist at Capital Health & Metabolic Center (part of Capital Diabetes & Endocrine Associates), Greater DC Area Lisa Murdock, Chief Advocacy Officer at the ADA Do you have questions or comments you'd like to share with Neil and Lucia? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to "follow" Diabetes Day by Day! Additional resources: Help drive change for affordable insulin by signing our petition today at diabetes.org/InsulinAct. Become a Diabetes Advocate at diabetes.org/BecomeAnAdvocate. Share your story today at diabetes.org/ShareYourStory. For all things advocacy, visit diabetes.org/Advocacy.

Drs. Jay Nair and Helen Milligan are both doctors of Physical Therapy at Thomas Jefferson University.  They joined us on the podcast today to talk about the concept of a Central Neural Drive and how this impacts people with Down syndrome.  They are conducting a study on this topic and are looking for participants.  For more information on the study, contact Dana R. Johnsn at nairlab@jefferson.edu, 215-326-9153.     If you would like to suggest a topic for us to cover on the podcast, please send an e-mail to DownSyndromeCenter@chp.edu. If you would like to partner with the Down Syndrome Center, including this podcast, please visit https://givetochildrens.org/downsyndromecenter. We are thankful for the generous donation from Caring for Kids – The Carrie Martin Fund that provides the funding for the podcast recording equipment and hosting costs for this podcast.

In this episode of Taking Healthcare by Storm, Quality Insights Medical Director Dr. Jean Storm speaks with Peter Kowey, MD, Professor of Medicine and Clinical Pharmacology at Thomas Jefferson University, Emeritus Chief of the Division of Cardiovascular Diseases at the Lankenau Heart Institute, and the William WikoffSmith Chair in Cardiovascular Research at the Lankenau Institute for Medical Research.Dr. Kowey discusses his book Failure to Treat, using patient-inspired stories to show how modern healthcare has grown less human and more complicated. He highlights harms from electronic medical records, profit-driven screening, malpractice-driven defensive medicine, administrative control, drug advertising, and burnout, and calls for universal access to basic care.If you have any topics or guests you'd like to see on future episodes, reach out to us on our website.The views and opinions expressed by the host and guests are their own and do not necessarily reflect the views, positions, or policies of Quality Insights. Publication number QI-061226-GK

Welcome to the latest episode (June 2026) of Diabetes Core Update, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Update: Shah S, et al. "Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort Diabetes Care. 2026;49(6):1067–1077. doi.org/10.2337/dc25-2727 Hespanhol L, et al. "Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis." Diabetes Care. 2026;49(6):1134–1143. doi.org/10.2337/dc25-2435 Tatum K, et al. "Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer." JAMA. Published Online: May 11, 2026 2026;9;(5):e2612133. doi:10.1001/jamanetworkopen.2026.12133 Winkler C, et al. "Screening Children for Early-Stage Type 1 Diabetes." JAMA. Published Online: May 21, 2026 doi:10.1001/jama.2026.6085 Würtz Yazdanfard P, Kosjerina V, Wood-Kurland H et al. "Effectiveness and Safety of Semaglutide in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018–2024)" Lancet. Volume 66, 101716, July 2026. doi:10.1016/j.lanepe.2026.101716 Horn D, Aronne L, Wharton S et al. "Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial." Lancet. Published online May 12, 2026. doi:10.1016/S0140-6736(26)00656-2 Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health For information about the American Diabetes Association's scholarly journals, visit diabetesjournals.org. For more about this podcast, click here.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Orforglipron for maintenance of body weight reduction  - Nature Medicine2026. Discussion by:Guest:Joe Gonella, MD Resident - Abington Family Medicine Residency Program Jefferson Health2. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN) Lancet 2026.  Discussion by: Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington3. Survival and Recurrence with GLP-1 Receptor Agonists in Breast Cancer" – JAMA Network Open Discussion by:Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington4. In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia.   NEJM 2026 Discussion by:Guest:Alex Sauer, MD Resident - Abington Family Medicine Residency ProgramJefferson HealthMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

There is a particular kind of authority that comes only from having been inside something for fifty years — from having seen it at its best, trained its practitioners, published its science, and then watched it hollow itself out from within.Dr. Peter Kowey has that authority. He holds the William Wickoff Smith Chair in Cardiovascular Research at the Lankenau Institute for Medical Research, is a professor of medicine and clinical pharmacology at Thomas Jefferson University, and spent years as chief of cardiovascular diseases at the Lankenau Heart Institute. He has published more than 450 scientific papers, trained hundreds of cardiology fellows, and served on FDA advisory panels. He has also, in the past several years, become someone who cannot stay quiet.His new book, Failure to Treat: How a Broken Healthcare System Puts Patients and Providers at Risk, is built from twenty short stories — each a fusion of real composite cases, each naming a different fracture in American medicine. Fragmented care with no coordinating physician. An electronic medical record redesigned to serve billing rather than patients. Defensive medicine that orders unnecessary tests because the malpractice system makes not ordering them dangerous. Private equity that purchases hospitals to strip and sell them. Primary care physicians asked to address four chronic conditions, review a medication list, conduct an exam, and dictate a note — in ten minutes.The book was born from a charge. Kowey's mentor was Dr. Bernard Lown: Nobel Peace Prize laureate, inventor of the defibrillator, one of the most morally serious physicians of the twentieth century. When Lown himself became a patient near the end of his long life, he encountered fragmented care, indifferent nurses, and cavalier doctors. He lived to 99, but not easily. In the years before his death, he told Kowey: "I'm really relying on you to try to do something about this."In this conversation, Kowey does not soften the diagnosis. The current administration, he says, has taken a broken system and made it exponentially worse: NIH funding running at half last year's levels, the CDC's expert panels cleared of independent scientists, vaccine skepticism in positions of authority, and cuts to Medicaid, Medicare, and veterans' healthcare that will take years to repair even if reversed tomorrow. He is blunt about what the fix requires: universal coverage, a salaried physician model, restored professional status for nurses, and loan relief tied to primary care service.He also holds out something harder to sustain than outrage: genuine hope. The people who go into medicine still go into it to help. That instinct, he believes, will outlast the systems that are trying to exploit it.The book is available on Amazon and wherever books are sold.Website:peterkoweyauthor.comIn this episode:Why fragmentation of care is the single most dangerous feature of modern American medicineHow the electronic medical record became an instrument of billing rather than careDefensive medicine, malpractice reform, and the billions they costPrivate equity in healthcare and the creation of hospital desertsThe ten-minute primary care visit and why physicians are leaving the fieldDirect-to-consumer drug advertising: the United States and New Zealand against the worldNIH, CDC, vaccines, and the public health erosion under the current administrationThe case for universal healthcare — and what getting there actually requires

In this special edition of Diabetes Core Update, Neil Skolnik discusses PATHWEIGH, a novel obesity care process for primary care clinicians which has demonstrated a decrease in population weight gain. This special episode is sponsored with support from Lilly. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Leigh Perreault, MD, Professor of Pedicine in the Division of Endocrinology, Metabolism and Diabetes, at the University of Colorado Denver School of Medicine, Aurora, CO Reference: Perreault, L., Pan, Q., Rodriguez, C. et al. Implementation and effectiveness of a care process to prioritize weight management in primary care: a stepped-wedge cluster-randomized trial. Nat Med 32, 645–652 (2026). 

In the first episode of this series on Obesity, our host is joined by Dr. Mikhail Kosiborod to discuss the evolving science and cardiometabolic diseases associated with obesity. This special episode is sponsored with support from AstraZeneca. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Mikhail Kosiborod, MD, Senior Vice President Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D at AstraZeneca. Selected references: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation October 2023

Carlos Juan Finlay was a Cuban doctor who did a lot of work to understand the spread of Yellow Fever. But Walter Reed got most of the credit. Research: American Experience. “Carlos Finlay (1833-1915).” From The Great Fever. PBS. https://www.pbs.org/wgbh/americanexperience/features/fever-carlos-finlay/ Berenbrok, Dorothy E., "Latin Heritage Month. Carlos Juan Finlay: Outrageous, Courageous and Correct" (2015). Posters: Jefferson History. 3. https://jdc.jefferson.edu/jeffhistoryposters/3 "Carlos Juan Finlay." Encyclopedia of World Biography Online, Gale, 1998. Gale In Context: Opposing Viewpoints, link.gale.com/apps/doc/K1631002194/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=bfeecc25. Accessed 29 Apr. 2026. Chaves-Carballo, Enrique. “Carlos J. Finlay: The mosquito man.” Hektoen International. 11/2/2020. https://hekint.org/2020/11/02/carlos-j-finlay-the-mosquito-man/ Corbitt, Duvon C. “Carlos J. Finlay, Cuban Physician.” The Hispanic American Historical Review, Vol. 45, No. 3 (Aug., 1965). Via JSTOR. https://www.jstor.org/stable/2511751 Del Regato, Juan A. “Carlos Juan Finlay (1833-1915).” Journal of Public Health Policy , 2001, Vol. 22, No. 1 (2001). Via JSTOR. https://www.jstor.org/stable/3343556 Faerstein, Eduardoa; Winkelstein, Warren Jrb. Carlos Juan Finlay: Rejected, Respected, and Right. Epidemiology 21(1):p 158, January 2010. | DOI: 10.1097/EDE.0b013e3181c308e0 Ferreira Moreno, Víctor Guillermo. “Evocation to the Dr. Carlos J. Finlay Barres on the centennial of his death.” Colombia medica (Cali, Colombia) vol. 47,1 63-6. 30 Mar. 2016 Finlay, Carlos J. “The Mosquito Hypothetically Considered as the Agent of Transmission of Yellow Fever.” Read before the Royal Academy of Medical, Physical and Natural Sciences Session of August 14th, 1881. https://archive.org/details/b33448541/page/590/mode/1up Finlay, Carlos Juan. “Trabajos selectos del Dr. Carlos J. Finlay. Selected papers of Dr. Carlos J. Finlay.” Habana. 1912. https://archive.org/details/trabajosselectos00finl Finlay, Charles. “Inoculations for Yellow Fever by Means of Contaminated Mosquitoes.” Published in The American Journal of the Medical Sciences, n.s. 102: 264-268, 1891. https://archive.org/details/b33445242/page/n4/mode/1up Finlay, Charles. “Yellow Fever: Its ‘Transmission by Means of the Culex Mosquito.” Published in The American Journal of the Medical Sciences, n.s. 92: 395-409, 1886. https://archive.org/details/b33435698/page/613/mode/1up Palmer, Steven. “A Cuban Scientist Between Empires: Peripheral Vision on Race and Tropical Medicine.” Canadian Journal of Latin American and Caribbean Studies / Revue canadienne desétudes latino-américaines et caraïbes, Vol. 35, No. 69, Special Issue: Landscapes of LatinAmerican Health, 1870-1970. Via JSTOR. https://www.jstor.org/stable/41800498 Spears, Ellen Griffith and Rosa López-Oceguera. “Carlos Juan Finlay, William Gorgas, and Walter Reed and the U.S. Army Yellow Fever Controversy: Competing Historical Memories.” Alabama Review The University of Alabama Press. Volume 74, Number 1, January 2021. https://doi.org/10.1353/ala.2021.0011 Stepan, Nancy. “The Interplay between Socio-Economic Factors and Medical Science: Yellow Fever Research, Cuba and the United States.” Social Studies of Science , Nov., 1978, Vol. 8, No. 4 (Nov., 1978). Via JSTOR. http://www.jstor.com/stable/284817 Thomas Jefferson University. “10 Notable Jefferson Alumni of the Past.” https://library.jefferson.edu/archives/exhibits/notable_alumni/juan_carlos_finlay.cfm Tone, John Lawrence. (2002) “How the mosquito (man) liberated Cuba.” History and Technology, 18:4, 277-308, DOI: 10.1080/07341512.2002.11417735 “Carlos J. Finlay.” 5/16/2023. https://www.unesco.org/en/prizes/carlos-j-finlay/about Woodall, Jack. "Yellow Fever." Infectious Diseases: In Context, edited by Brenda Wilmoth Lerner and K. Lee Lerner, vol. 2, Gale, 2008, pp. 925-931. In Context Series. Gale In Context: Opposing Viewpoints, link.gale.com/apps/doc/CX3045200265/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=bf646a26. Accessed 29 Apr. 2026. See omnystudio.com/listener for privacy information.

Living with diabetes means paying attention to your health in ways others may never fully understand, and eye health is one of the most important parts of that journey. For Healthy Vision Month, this episode of Diabetes Day by Day features Sterling Glass sharing his personal diabetes and eye health journey, and why protecting vision is so important for people living with diabetes. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Lucia M. Novak, MSN, ANP-BC, BC-ADM, President and Founder of Diabesity LLC; Co-Executive Director, Diabetologist, and Obesity Management Specialist at Capital Health & Metabolic Center (part of Capital Diabetes & Endocrine Associates), Greater DC Area Sterling Glass, Diabetes Advocate living with type 1 diabetes and a member of the Blind Boys of Alabama Do you have questions or comments you'd like to share with Neil and Lucia? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to "follow" Diabetes Day by Day! Additional resources: Learn more about diabetes and eye health at diabetes.org/EyeHealth and enjoy the music of the Blind Boys of Alabama on their Spotify playlist. Read more about Sterling's journey.

Is hypercortisolism the hidden culprit in a significant proportion of both difficult-to-treat diabetes and resistant hypertension? In part 4 of our special series, Dr. Neil Skolnik speaks with John Buse, MD to explore the effects of hypercortisolism, until just recently considered a vanishingly rare condition. This special episode is sponsored with support from Corcept. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John Buse, MD, The Verne S. Caviness Distinguished Professor and director of the Diabetes Center at the University of North Carolina at Chapel Hill School of Medicine, a past president of medicine & science at the American Diabetes Association (ADA), and recipient of the ADA Outstanding Achievement in Clinical Diabetes Research Award Selected references: Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care April 2025 Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment. Diabetes Care June 2025 MOMENTUM: Hypercortisolism Present in 1-in-4 with Resistant Hypertension. HCP Live March 2026

We have only recently become aware of the close relationship between the heart and the kidneys. In today's discussion, Dr. Neil Skolnik speaks with Dr. Josephine Harrington to gain insight into these newly-discovered links between cardiovascular risk and CKD. This special episode is sponsored with support from Bayer. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: -Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health -Josephine Harrington, M.D., Assistant Professor of Medicine in the Division of Cardiology at the University of Colorado School of Medicine. Selected references: -Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026. The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1):S246–S260 -Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 2020;383:2219-2229 -Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 2020;383:1436-1446 -Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med 2024;391:109-121

In this episode, we discuss the use of aflibercept 8mg for the management of retinal vein occlusion and the results of the QUASAR study with Dr. Sunir Garg, Co Director of Retina Research at the Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.

What has changed in the updated 2026 Surviving Sepsis Campaign (SSC) guidelines for children? In this episode of the Society of Critical Care Medicine (SCCM) Podcast, host Elizabeth H. Mack, MD, MS, FCCM, speaks with pediatric SSC guideline cochairs Scott L. Weiss, MD, MSCE, FCCM, and Pierre Tissieres, MD, DSc, about the latest guideline recommendations for the care of children with sepsis and septic shock. The updated guidelines emphasize the early identification of sepsis, an evolution to a more targeted way of treatment, and a more practical approach to guideline implementation. Other aspects of the previous guidelines, such as lactate measurements, continuous reassessment, and the role of point-of-care monitoring, were reinforced in the 2026 guidelines. The guidelines, “Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026,” were released in the April issue of Pediatric Critical Care Medicine. Key updates and new areas of emphasis include:   A more nuanced approach to sepsis screening and early recognition  New guidance on supplemental oxygen, including limiting hyperoxia and using more conservative oxygenation targets in children with septic shock  New patient, intervention, comparison, outcome questions related to immune dysregulation, highlighting an important area for future research  New attention to post-sepsis morbidity  Greater emphasis on long-term follow-up and risk assessment for children who survive sepsis Scott L. Weiss, MD, MSCE, FCCM, is division chief of critical care and vice-chair of research at Nemours Children's Hospital (DuPont)-Delaware and professor of pediatrics and pathology and genomic medicine at the Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Pierre Tissieres, MD, DSc, is a professor of pediatrics and head of Pediatric ICU and Neonatal Medicine at Paris South University Hospitals in Paris, France. This podcast is sponsored by Vantive.  At Vantive, our mission to extend lives and expand possibilities starts with a commitment to continuous learning. We are committed to partnering with the medical community to support vital organ therapy innovation grounded in clinical evidence and focused on improving patient outcomes. The recent publication on endotoxic septic shock centers on an evidence-based approach to address clinical challenges in critical care and beyond as highlighted in our press release. Resources referenced in this podcast:  Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026  Executive Summary of Society of Critical Care Medicine 2026 Guidelines on the Care and Management of Pediatric and Neonatal Intensive Care Patients at the End of Life  International Consensus Criteria for Pediatric Sepsis and Septic Shock

In the early 2000s, long-acting, once-daily insulin was approved, completely changing the experience of using insulin for people with diabetes. But science doesn't stand still. Now the FDA has approved weekly insulin. In this special episode of Diabetes Core Update, Neil Skolnik speaks with Athena Philis-Tsimikas, MD about this exciting development. This special edition of Diabetes Core Update is sponsored with support from Lilly. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: -Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health -Athena Philis-Tsimikas, MD, Corporate Vice President of the Scripps Whittier Diabetes Institute and Diabetes Care Line at Scripps Health in San Diego, CA

All Bones Considered: Laurel Hill Stories #086, part 3 These brothers-in-law were best friends. Potter served as President of Thomas Jefferson University for many years despite the lack of a college degree. Vanuxem left a legacy for Princeton which is still being celebrated. 

All Bones Considered: Laurel Hill Stories #086 for May 1, 2026 I was tied up with preparing some new tours and could not finish the podcast on the Bible Riots of 1844. I scrounged around and found a few scripts I had written and never used. And then I remembered a segment that Thomas Keels recorded for me for an abandoned project.  Francis Lilly Sully Darley was the grandson of a great portrait painter who married the daughter of Matthias Baldwin and became the most sought-after organist and choir director in the city. The Kindred Brothers went west to Minnesota and North Dakota and became fabulously wealthy with their shady railroad real estate deals. One served as mayor of Fargo.  William Potter and Louis Clark Vanuxem were best friends and brothers in law. Through years of dedication, Potter's name is inextricably tied with Thomas Jefferson University, while Louis's name is preserved at Princeton. Fellow guide and amateur historian Thomas Keels tells the story of how the Great Profile Shakespearean actor John Barrymore ended up without a marker in a nearly abandoned cemetery decades after his demise.   

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes Results From the VESALIUS-CV Trial. JAMA 2026. Discussion by:Guest:Jessica Stieritz, MDResident - Abington Family Medicine Residency Program Jefferson Health2. A treat-to-target strategy versus symptom-driven management of gout in the Netherlands (GO TEST Overture): a multicentre, open-label, pragmatic, superiority, randomized controlled trial. Lancet Rheumatology 2026. Discussion by:Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington3. Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients. NEJM 2026 Discussion by: Guest:Steven Leonard, MD Resident - Abington Family Medicine Residency Program Jefferson HealthMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Send us Fan MailDr. Zubair Aghai, neonatologist at Thomas Jefferson University in Philadelphia, presents results from one of the largest neonatal trials ever conducted — enrolling 3,448 late preterm and term infants across India to test whether umbilical cord milking in non-vigorous newborns reduces death or moderate-to-severe HIE. With over 100,000 deliveries screened and real-time data collected by research staff present at every delivery around the clock, the primary outcome showed no short-term harm from cord milking — and a secondary signal of reduced infection risk, possibly driven by the immunoglobulins transferred with the extra blood. He also explains why non-vigorous babies stand to gain the most from this simple ten-second intervention, and previews two-year neurodevelopmental follow-up data still to come.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

Managing diabetes means taking care of your whole body, and this includes your feet. In this episode, you'll hear about why foot care is so important and how small, daily habits can make a big difference in preventing serious problems.  Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Lucia M. Novak, MSN, ANP-BC, BC-ADM, President and Founder of Diabesity LLC; Co-Executive Director, Diabetologist, and Obesity Management Specialist at Capital Health & Metabolic Center (part of Capital Diabetes & Endocrine Associates), Greater DC Area Cyaandi Dove, DPM, Director of Podiatry and Director of the Diabetic Foot Clinic at Oregon Health & Science University in Portland, Oregon Do you have questions or comments you'd like to share with Neil and Lucia? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to "follow" Diabetes Day by Day! Additional resources: Interested in learning more? Learn more at diabetes.org/FootHealth.

In this special edition on Emerging Technologies for People with Diabetes our host, Dr. Neil Skolnik will discuss recent and future advances in technologies for people with diabetes. This special episode is supported by an independent educational grant from Seagrove Partners. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Erik Veerhoef, Founder, President and CEO of Seagrove Partners

In this episode of RAPM Focus, Editor in Chief Brian Sites, MD, discusses the pros and cons of perioperative gabapentinoids with author and RAPM Executive Editor Eric Schwenk, MD, and Kishor Gandhi, MD, following the November 2025 publication of his brief technical report, “Pro-con debate on perioperative gabapentinoids: a nuanced approach is the best one.” Dr. Eric Schwenk is a professor of anesthesiology and perioperative medicine at the Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, PA and is the vice chair of faculty affairs and professional development. His clinical and research interests are outcomes after orthopedic surgery, chronic postsurgical pain, and ketamine in migraine. He serves on the ASRA Pain Medicine Guidelines and Regulatory Advocacy Committee. Dr. Kishor Gandhi is a clinical associate professor and associate residency director at Virtua College of Medicine and Life Sciences at Rowan University in New Jersey. His clinical interests include regional anesthesia and acute pain. Dr. Gandhi has been in clinical practice for 20 years. *The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner's judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others. Podcast and music produced by Dan Langa. Find us on X @RAPMOnline, LinkedIn @Regional Anesthesia & Pain Medicine, Facebook @Regional Anesthesia & Pain Medicine, and Instagram @RAPM_Online.

In this special edition on Continuous Ketone Monitoring our host, Dr. Neil Skolnik will discuss this new technology – its promise and its application. This special episode is supported by an independent educational grant from Abbott. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Guillermo Umpierrez, M.D.,  Professor of Medicine, Division of Endocrinology, Clinical Director of the Diabetes and Metabolism Center at Emory University School of Medicine, Director of the Diabetes and Endocrinology Section and Clinical Research Unit at Grady Memorial Hospital, Atlanta, Georgia. Member of the ADA Professional Practice Recommendation Committee, and Chair of the ADA Consensus Report on Hyperglycemic Crises in Adults with Diabetes.   Reference: Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care 2024;47:1257–1275 | https://doi.org/10.2337/dci24-0032

As wildfire season ramps up across the state, The Spark spoke with Mike Kern, Chief of the Division of Forest Fire Protection, and Matt Reed, Chief of Wildfire Operations and Planning with the Pennsylvania Bureau of Forestry, about what residents need to know. They explained that most wildfires in Pennsylvania are human-caused—often the result of debris burning, unattended campfires, or discarded cigarettes—making prevention a critical part of safety. With dry conditions and shifting winds increasing fire risk, they emphasized the importance of following local burn bans, properly extinguishing fires, and staying aware of changing weather conditions. Kern and Reed also highlighted how their teams prepare year-round to respond quickly and protect both people and natural resources, urging Pennsylvanians to stay informed and take simple precautions to help reduce wildfire risk. On a recent episode of The Spark, we discussed the future of hemp fiber in Pennsylvania with Gabriella Fioravanti of Thomas Jefferson University and Mike Roth of the Pennsylvania Department of Agriculture. The conversation focused on how hemp fiber can be used in products like textiles and building materials, the environmental benefits it offers, and the challenges—like processing infrastructure—that are shaping the industry's growth in the state.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

We Talk Weekly News is a weekly news and culture podcast delivering powerful analysis, real conversations, and unfiltered commentary on the biggest stories shaping our world today. On WPPM 106.5 FM Philadelphia every Saturday at 8 p.m. to 10 p.m., Hosted by celebrity stylist & radio personality Charles Gregory, journalist and media personality Lauren "Sizzle" Settles and health correspondent "Classy Lady" Sparkle Howell. We feature expert guests, political and public figures, celebrities, and community leaders combined with legal and law enforcement analysis and commentary.We Talk Weekly News takes you beyond the headlines with breaking news, political analysis, entertainment updates, and trending cultural conversations all through a sharp, informed, and unapologetically urban lens. From U.S. politics and policy to global events, celebrity headlines, music, and the viral moments everyone's talking about — this is where news meets culture and perspective meets truth.In this segment, we interview:Dr. Nia Imani Bailey, DPA, M.A.Ed., RT(T), is a proud West Philadelphia native whose life's work is rooted in service, advocacy, and the empowerment of vulnerable communities. With more than a decade of experience as a Radiation Therapist, she has seen firsthand the barriers cancer patients face—experiences that continue to fuel her mission to bridge healthcare, education, and community advocacy with compassion and purpose.Dr. Bailey earned her Doctorate in Public Administration from West Chester University, where her research centered on improving the timely diagnosis of breast cancer in young women and advancing policy reforms to expand equitable healthcare access. She holds a Bachelor's degree in Allied Health with a concentration in Radiologic Sciences from Immaculata University, completed through a 3+1 program in partnership with Thomas Jefferson University. She went on to earn a second Bachelor's degree in Radiologic Sciences with a concentration in Radiation Therapy from Thomas Jefferson University. While working full-time in clinical care, she also completed her Master's degree in Education at La Salle University, specializing in Bilingual and Bicultural Studies.As a patient living with lupus and carrying the BCL6 cancer gene, Dr. Bailey brings both professional expertise and deeply personal insight to her work. This dual perspective strengthens her advocacy and allows her to champion more compassionate, equitable, and accessible care for all.Dr. Bailey serves as President of the Byrd Cancer Education & Advocacy Foundation and volunteers with several organizations, including Live Like Lukas, Inc. and the Pink Lemonade Stand Challenge. A gifted storyteller, she is the writer and director of the documentaries A Letter to My Sisters: A Breast Cancer Documentary for Young Women and A Letter to My Sisters: The Erica Jo Robinson Story. She also authored the foreword for 10 Most Powerful Ways to Kick Cancer's Ass: Survival Kit.In addition, she is the author of the children's books Love Thy Neighbor and Letters To My Younger Self. Dr. Bailey lends her expertise as an Advisor for the Bexa Equity Alliance, a member of the Unite for HER Women of Color Task Force, and a board member for both Still Rise Farm Organization and the Habituelle Board of Innovators. In recognition of her leadership and community impact, she was appointed by Pennsylvania Governor Josh Shapiro to the Governor's Advisory Commission on African American Affairs, representing Philadelphia County, Co-Chair of the Health Subcommittee.Through her multidisciplinary work in healthcare, policy, storytelling, and advocacy, Dr. Nia Imani Bailey continues to uplift and inspire—transforming her personal journey into a powerful movement for education, equity, and hope. Her life's mission is to honor God and be obedient to Him.Become a supporter of this podcast: https://www.spreaker.com/podcast/we-talk-weekly-news--2576999/support.Subscribe to We Talk Weekly News' YouTube channel for full podcast video show episodes:https://www.youtube.com/@WeTalkWeeklyTVFollow We Talk Weekly News across all social media platforms for exclusive content, breaking updates, and behind-the-scenes access:Instagram: https://www.instagram.com/wetalkweeklyTwitter (X): https://twitter.com/WeTalkWeeklyFacebook: https://www.facebook.com/wetalkweekly

This issue will review: 1.     Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide 2.     Estimated Optimal Individualized Diabetes Risk Prediction From Preventive Interventions in the U.S. General Population 3.     Impact of Metabolic Bariatric Surgery on Weight Loss and Glycemic Control in Adults With Type 1 Diabetes 4.     Finerenone in Type 1 Diabetes and Chronic Kidney Disease 5.     Effects of Sodium/Glucose Cotransporter-2 Inhibitor Use on Mortality, Amputation, and Healing in Patients With Diabetic Foot Ulcer Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's science and medical journals – Diabetes, Diabetes Care, and Diabetes, Obesity, and Cardiometabolic CARE, and beyond. Each episode is approximately 25 minutes long and presents recently published articles from ADA journals and more. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study. BMJ 2026. Discussion by:Guest:Susan Kucher, MDProgram Director - Abington Family Medicine Residency Program Jefferson Health2. Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes Results From the VESALIUS-CV Trial. JAMA. Discussion by:Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington3. Prevalence of Youth Overweight, Obesity, and Severe Obesity. JAMA Network Open. Discussion by:  Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington4. A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide. New England Journal of Medicine 2026. Discussion by:Guest:Griffin Johnson, MDResident - Abington Family Medicine Residency Program Jefferson HealthMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.

Advocacy helps improve access to care, medications, and technology. It also helps bring real-life diabetes experiences to lawmakers who shape important policies. In this episode, you'll hear about one advocate's experience at our Call to Congress in Washington, DC, where community members meet to share their stories and push for change.   Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Lucia M. Novak, MSN, ANP-BC, BC-ADM, President and Founder of Diabesity LLC; Co-Executive Director, Diabetologist, and Obesity Management Specialist at Capital Health & Metabolic Center (part of Capital Diabetes & Endocrine Associates), Greater DC Area Danica Collins, MS, NBC-HWC, San Diego-Based Hospital Consultant, Board Certified Health Coach, Diabetes Advocate, and Founder of Dia-Log the Insulin for Your Soul Do you have questions or comments you'd like to share with Neil and Lucia? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to "follow" Diabetes Day by Day! Additional resources: Interested in becoming an advocate? Sign up today. You can also learn more about our advocacy efforts and initiatives on our site. 

In this special edition on Obesity as a Chronic Disease our host, Dr. Neil Skolnik will discuss the approach to treatment of obesity. This special episode is supported by an independent educational grant from Lilly. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Robert Kushner, M.D, Professor Emeritus of Medicine and Medical Education, Northwestern University Feinberg School of Medicine, former Director of the Center for Lifestyle Medicine at Northwestern Medicine, Chicago, IL.  Past-President of The Obesity Society, the American Society for Parenteral and Enteral Nutrition (ASPEN), the American Board of Physician Nutrition Specialists (ABPNS), and a founder and past-Chair of the American Board of Obesity Medicine (ABOM). Reference: Developed by the Obesity Association's Professional Practice Committee, with input and support from multiple obesity and medical organizations, The Standards of Care in Overweight and Obesity offers a groundbreaking roadmap to empower health care professionals with the tools necessary to deliver the best possible evidence-based, pragmatic care to people with overweight and obesity.

We've spoken with many guests about clinical and technological trends impacting healthcare providers, but less so about the trends on the business side of practicing medicine.  So on this episode, we're going to make up for that by spending our time with Dr. Alexander Vaccaro, an influential spine surgeon and president of one of the largest musculoskeletal practices in the U.S. -- Rothman Orthopaedic Institute -- which treats patients at over 40 locations in Pennsylvania, New Jersey, New York and Florida. While Dr. Vaccaro understands the desire for financial stability that's increasingly driving young physicians into the arms of hospital systems, he worries about what's being lost with the resulting decline in the number of independent practices.  “If you didn't have private practice advocating for the doctor, the insurance companies would bully the healthcare profession.” Join Raise the Line host Michael Carrese for a candid and lively conversation that also covers: How physician autonomy and entrepreneurship can drive innovation; The economic and policy forces reshaping private practice medicine; The role of research partnerships between private practices and universities. Mentioned in this episode:Rothman Orthopaedics If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this special edition on Obesity as a Chronic Disease our host, Dr. Neil Skolnik will discuss epidemiology, pathophysiology and screening for CKD in People with Diabetes. This special episode is supported by an independent educational grant from Bayer. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Holly Kramer, M.D., Professor of Public Health Sciences and Medicine in the Division of Nephrology and Hypertension at Loyola University Chicago, past-president of the National Kidney Foundation, Editor-in-Chief of the National Kidney Foundation's journal,  Advances in Kidney Disease and Health (AKDH).   Selected references: Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 . The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1) :S246–S260  

In this special edition on Diabetes and Primary Care our host, Dr. Neil Skolnik will engage in an interesting discussion about the challenges, opportunities, and changing face of primary care in the management of diabetes and cardiometabolic disease.  Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Osagie Ebekozien, M.D.,MPH, CPHQ,  Chief Quality Officer for the American Diabetes Association (ADA). In this role, he leads ADA efforts to transform diabetes and obesity quality outcomes and improving access to evidence-based practice.   Christopher Jones, M.D., Medical Director, Internal Medicine Intermountain Health, Murray, Utah; Chair of the American Diabetes Association's Primary Care Interest Group Leadership Team.

What is the real killer when it comes to heart disease? Can the right cardiac testing truly mean the difference between life and death? In today's episode, we are joined by Dr. John Osborne, a Harvard-trained, triple board-certified cardiologist and Co-Founder of ClearCardio, to break it all down… Dr. Osborne earned his B.S. with honors from Penn State University, his M.D. magna cum laude from Jefferson Medical College, and a Ph.D. in cardiovascular physiology from Thomas Jefferson University. His postdoctoral training at Harvard Medical School and Brigham and Women's Hospital helped shape his expertise in non-invasive cardiology. Board-certified across multiple disciplines, his work focuses on preventive cardiology, metabolic syndrome, and cardiovascular genetics. Recognized as the American Heart Association's Cardiac Care Provider of the Year and named a Top Doctor multiple times, Dr. Osborne has authored original research papers, book chapters, and delivered hundreds of international presentations. Through ClearCardio, he is advancing proactive cardiac care by integrating AI-powered imaging to detect plaque earlier, quantify risk more precisely, and empower patients before symptoms appear. In this episode, we dive into: What actually causes heart attacks and sudden cardiac death. The role of soft plaque vs calcified plaque in coronary artery disease. Why many heart attacks happen after a "normal" stress test. The limits of stents and why they do not necessarily extend longevity. To learn more about Dr. Osborne and his work with ClearCardio, connect with him on LinkedIn!

Dr. Daniel Monti is the founding chair of the first integrative medicine department at an American medical university.Rather than treating symptoms in isolation, integrative medicine takes a holistic approach to health, combining conventional Western medicine with mind-body therapies, nutritional medicine, and traditional practices such as acupuncture and herbal medicine.“Integrative medicine,” Monti told me, “has become a subspecialty of medicine with its own board certification. ... To become an integrative medicine doctor, you have to first do your residency in something like internal medicine, neurology, OBGYN, and then do a fellowship in integrative medicine.”Monti, who holds board certifications in both psychiatry/neurology and holistic/integrative medicine, said that integrative physicians “take a deep dive into whole-person health and understanding who the person is.” They look, for example, at genomics, the patient's microbiome, and maximal oxygen consumption.A powerful technique Monti studied in depth is the neuro-emotional technique (NET), developed in the 1980s. It's a mind-body therapy designed to release emotional stress from within the body. And through advanced brain scans, they can see how the brain changes after applying the technique to alleviate distress.NET merges principles from conventional medicine with traditional Chinese medicine and psychology, he says. The goal is to “get at what is underneath the issue that's bothering the person. ... Most of the time I'm experiencing a block in my life in some way. And then we have to kind of figure out what the life experiences were that are contributing to that present-day block.”During the interview, Monti used me as a test subject to demonstrate the integrative medicine technique.We also discuss additional integrative medicine therapies, such as vitamin infusions and stress-reduction treatments. We also dive into a recent study into a powerful antioxidant's power to benefit Parkinson's patients.Monti is the founder and CEO of the Marcus Institute of Integrative Health and chair of the Integrative Medicine and Nutritional Sciences at Sidney Kimmel Medical College, Thomas Jefferson University. He's the co-author of “Brain Weaver” and “Tapestry of Health.”He's also the host of “House Call with Dr. Dan Monti.”Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.

This issue will review: 1.     Real-World Prospective Validation and Economic Evaluation of Deep Learning-based Diabetic Retinopathy Detection from Fundus Photographs: A Systematic Review and Meta- Analysis 2.     Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial 3.     FDA removal of SI for GLP-1s – FDA Announcement Neil Read/John Comment 4.     Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk: A Target Trial Emulation Study 5.     GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients with Type 2 Diabetes or Cardiometabolic Diseases: A Meta-Analysis of Randomized Controlled Trials  Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

In today's episode, Lindsey is joined by Dr. Sara Szal Gottfried MD, Director of Precision Medicine at the Marcus Institute of Integrative Health at Thomas Jefferson University, and multiple New York Times bestselling author, to journey into the world of psychedelic medicine and autoimmunity. Morning Microdose is a podcast curated by Krista Williams and Lindsey Simcik, the hosts and founders of Almost 30, a global community, brand, and top rated podcast. With curated clips from the Almost 30 podcast, Morning Mircodose will set the tone for your day, so you can feel inspired through thought provoking conversations…all in digestible episodes that are less than 10 minutes. Wake up with Krista and Lindsey, both literally and spiritually, Monday-Friday. If you enjoyed this conversation, listen to the full episode on Spotify here and on Apple here.

In this special edition on Obesity as a Chronic Disease our host, Dr. Neil Skolnik will discuss the root causes of obesity, the hormonal changes and metabolic adaptation that occurs when a person has obesity, and the implications of understanding obesity as a chronic disease for clinical practice. This special episode is supported by an independent educational grant from Lilly. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Donna Ryan, M.D, Professor Emeritus at the Pennington Biomedical Research Center in Baton Rouge, Louisiana. Past President of both the Obesity Society and the World Obesity Federation Susan Kuchera, M.D, Associate Clinical Professor of Family and Community Medicine in the Sidney Kimmel Medical College of Thomas Jefferson University, Program Director of the Jefferson Health Abington Family Medicine Residency Program. Selected references: Changes in Energy Expenditure Resulting from Altered Body Weight. N Engl J Med 1995;332:621-628 Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med 2011;365:1597-1604

In part three of this series, Dr. Jeff Ratliff discusses how access to information is not the same as clinical confidence. Show transcript:  Dr. Jeff Ratliff:  Hi, this is Jeff Ratliff from Thomas Jefferson University, and this is your Neurology Minute. I'm back again with a Neurology Minute episode to complement the podcast discussion I had with Roy Strowd, Justin Abbatemarco, and Tesha Monteith on the topic of technology-driven shifts in neurology education. In the episode, we touched on podcasting, AI-based learning, and social media on neurology education as a panel discussion. While there is still tremendous utility and promise and excitement around these tools, I think it's still helpful for us all to remember that access to information is not the same as clinical confidence. With tools like podcasts, learners can hear expert discussions on their commute or review topics in new interactive formats. With AI tools, learners can simulate talking to patients with a multitude of neurologic conditions. These digital tools can provide answers at hours, and our learners fingertips much more readily than even recent years. But as we watch the explosion of these tools impact, we must keep in mind the value of bedside clinical teaching. As teachers, as educators, there's still a great impact we can have by watching a resident examine a patient with ataxia, or coaching them through a difficult conversation with a patient. We can still help them teach the skill of reasoning through their clinical encounters in real time so that they can remember to ask that key history question, or to add in that critical exam maneuver. So, as impressive and impactful the latest and greatest teaching tool may be, I encourage you all not to shy away from going back to the bedside with the student, the resident, or fellow working with you today. Thanks for listening to the Neurology Minute. We'll see you next time.

In part two of this series, Dr. Jeff Ratliff discusses the expanding role of AI and digital tools in neurology education, emphasizing the importance of verifying information and developing source literacy.  Show transcript:  Dr. Jeff Ratliff: Hi, this is Jeff Ratliff from Thomas Jefferson University, and this is your Neurology Minute. I recently recorded a podcast episode with Roy Stroud, Justin Abadamarko, and Tisha Monteith, where we discussed the growing impact of technology in neurology education. In this episode, we touched on podcasting, AI-based learning and social media in neurology education, all as a panel discussion. As an accompaniment to that conversation, we're releasing a series of Neurology Minute episodes, exploring those tools. Today I want to focus an important caution, verification. With increasing use of digital tools, AI or otherwise. The need for caution and verification of sources is even more important. Large language models and other AI tools are very frequently used by trainees at all levels. To summarize topics, generate explanations, and even draft a differential diagnosis. But as you all know, the outputs of these tools can be efficient and really impressive, but we need to keep in mind that potential issues with reliability. While less and less common, these tools may hallucinate producing information that sounds authoritative and sounds correct, but it's actually outdated or maybe even unsupported by evidence. So for those of us teaching at the bedside or in clinic, this means we have a responsibility to help our learners develop literacy towards AI and other digital tools. We have to be critics of our sources. As neurologists, we can role model asking questions like, where did this information come from and how do we verify it, and did you read the study that they cited? We encourage trainees to trace these claims back to the primary literature or to pull up guidelines or other trusted review sources just as we do in our own practice. I don't want to pour water on the AI enthusiasm. The truth is still that AI education tools can be a powerful adjunct for learning, but we should treat it like an assistant, not a supervisor. It's useful, it's fast, but it's still in need of our own supervision. Please tune into our podcast discussion to hear more about the rapidly changing landscape of neurology education. Meanwhile, thanks for listening to the Neurology Minute.   

In this special series on Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated steatohepatitis (MASH) our host, Dr. Neil Skolnik will discuss diagnosis and treatment of MASH using a case-based approach with two master clinicians, one a hepatologist and the other a primary care physician. This special episode is supported by an independent educational grant from Boehringer Ingelheim. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Alina M. Allen, M.D. Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota, where she serves as the Director of Hepatology and Director of the MASLD Clinic. Susan Kuchera, M.D. - Program Director of the Jefferson Health Abington Family Medicine Residency Program, Clinical Associate Professor of Family and Community Medicine in the Sidney Kimmel Medical College of Thomas Jefferson University Selected references: Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care 2025;48(7):1057–1082  

In this special series on Oral GLP-1 Receptor Agonists, Dr. Neil Skolnik will discuss the first of the GLP-1 RAs to receive FDA approval, Semaglutide.  This special episode is sponsored with support from Novo Nordisk. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health W. Timothy Garvey, MD.,  Butterworth Professor and University Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham. Selected references: Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Knop, Filip K et al. The Lancet, Volume 402, Issue 10403, 705 – 719 Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. Wharton Sean et al. N Engl J Med 2025;393:1077-1087 Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. Lincoff, A Michael, et al.  N Engl J Med 2023;389:2221-2232  

Today, I have the privilege of connecting with Dr. Sara Gottfried! Dr. Sara is a board-certified physician who graduated from Harvard and MIT. She practices evidence-based, integrative, precision, and functional medicine. She is a Clinical Assistant Professor in the Department of Integrative Medicine and Nutritional Sciences at Thomas Jefferson University and Director of Precision Medicine at the Marcus Institute of Integrative Health. She has written four New York Times bestselling books, including her latest, Women, Food and Hormones.  Dr. Sara is one of my favorite doctors in integrative medicine and GYN! In this episode, we dive into the infodemic, how stress impacts hormones, the impact of age-related changes on hormonal regulation, alcohol, and gender differences with ketogenic lifestyles. We discuss some lesser-known hormones, including growth hormone, and how to support them properly. We touch on disordered eating, how trauma influences our relationship with food, epigenetics, and the role of a lifetime relationship with food. We also look at methylation, glutathione, detox reactions, supporting physical detoxification, and our toxic diet culture. I hope you benefit as much from this episode as I did!  IN THIS EPISODE YOU WILL LEARN: Dr. Sara explains what an infodemic is and how it has affected how she communicates with her patients.  What happens to our hormones as we age? The impact of stress on hormone regulation. Dr. Sara busts the myth that testosterone is a male hormone and discusses what testosterone means for women. How does alcohol consumption impact women's hormones? Why do men tend to have an easier time with the ketogenic diet than women? The dramatic changes that occur in women's bodies as they transition from perimenopause to menopause. Looking at the interrelationship between trauma, stress, and autoimmunity. The changes that occur with growth hormones as we age. How trauma affects the genes. How disordered eating impacts metabolism. How to support physical detoxification naturally, without going to extremes. How to address weight-loss plateaus. Connect with Cynthia Thurlow Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community (The Midlife Pause/Cynthia Thurlow)  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause supplement line Connect with Dr. Sara Gottfried On her ⁠website⁠ ⁠Facebook⁠, ⁠Instagram⁠ Dr. Sara's books are available on https://www.saragottfriedmd.com/ and ⁠Amazon.⁠

“First we shape our buildings, thereafter they shape us.” - Winston Churchill (attributed)The natural world is humanity's original habitat. This habitat supports our physiological energy efficiency and is an important health intervention for the AEC industry. These are core perspectives that Helena van Vliet shares in this joint PHA-Building Science Podcast interview. Helena makes the clear case that we are “open systems” - we take in our environments, both physically and with our perceptions. Whether outdoors or indoors, our physical selves have their own experience of each environment we inhabit. This experience first informs our bodies, which have their own reactions of ease or dis-ease; and next, seemingly at the same time, this experience then informs our minds and our psychological reality comes to life. This interview is yet another beacon guiding us to deeply rethink how we deliver indoor spaces to ourselves. Enjoy the nourishing feast of ideas here!Helena van VlietHelena van Vliet Dipl.-Ing. AIA is an internationally recognized expert in Biophilic Design. She is a registered Architect, Consultant, Researcher, Educator, and Speaker focusing on the direct connections between human and bio-habitat resilience in built environments. In her designs, consulting work and teaching, she integrates insights from her 40 years of practice, as well as data from her ongoing research in evolutionary biology, cognitive neuroscience, biopsychology, and chronobiology. Helenais the Principal at Helena van Vliet LLC, as well as a founding member of BioPhilly. Since 2013, she has served as a Steering Committee Member for the International Biophilic Cities Network.Since 2018, Helena has taught her interdisciplinary seminar “Environments for Well-Being” at Thomas Jefferson University, bringing together design and health science students to explore the building blocks - and underlying science - of spaces that support well-being. She is a frequent lecturer at the University of Pennsylvania, Drexel, Widener, the Bauhaus University Weimar, Germany, and the Politecnico di Milano, Italy.Ilka CassidyIlka Cassidy, Dipl.-Ing. Architecture, CPHC, is the co-founder of C2 Architecture and Holzraum System, with a deep passion for Passive House envelope design and building science. She focuses on the benefits of using natural building materials and specializes in offsite construction.With extensive experience in Passive House consulting and energy modeling, Ilka has a strong understanding of energy efficiency strategies. As a co-founder of C2 Architecture, she brought a sustainable design perspective to the firm from its inception. Through Holzraum System, she has worked to merge the precision and scalability of prefabrication with the use of healthy, low-carbon materials, all while optimizing energy efficiency with Passive House principles.Ilka is also committed to expanding knowledge in the industry, serving as co-host of the Passive House Accelerator Podcast and Construction Tech Live events. She is a frequent conference speaker and an active member of Green Building United in Philadelphia. She is a proud mom for her three girls and a visiting educator and McGill University. TeamHosted by Kristof IrwinEdited by Nico MignardiProduced by M. Walker

Today we discuss Alternative revenue streams for physicians! So what are some things doctors can do outside of the clinic to make some revenue? We discuss some things in this episode!   Alfred Atanda Jr., MD, is the director of the Sports Medicine Program, and a pediatric orthopedic surgeon and sports medicine specialist. He serves as assistant professor of orthopedic surgery and pediatrics at Sidney Kimmel Medical College of Thomas Jefferson University. Dr. Atanda is a graduate of the University of Pennsylvania School of Medicine, completed an internship and orthopedic surgery residency at the University of Chicago Medical Center, and fellowships in pediatric orthopedic surgery at Nemours Children's and in sports medicine at the Rothman Institute at Thomas Jefferson University. He performs arthroscopic surgery of the knee, elbow, ankle and shoulder, as well as general orthopedic and trauma surgical procedures. His research interests are in upper extremity overuse injury prevention and general orthopedic trauma. Recently, he has developed an interest in technology and digital health innovation and routinely uses telemedicine in his sports medicine practice. He is working with several stakeholders in the organization to re-imagine the process by which pediatric orthopedic patients are triaged, navigated, evaluated and treated during the continuum of their health care experience. Provides care in Wilmington, Del., and Abington, Pa.   We answer questions you may have on the things you will encounter when it comes to billing, like: What is an IME? Expert Witness + more